Last updated on November 2017

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents


Brief description of study

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Detailed Study Description

Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more

Clinical Study Identifier: TX10550

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Northwest Clinical Research Center

Northwest Clinical Research Center
Bellevue, WA USA
  Connect »

Kaley Killdahl

APG Research, LLC
Orlando, FL USA
  Connect »